Basics Roivant Sciences Ltd. Common Shares IPO Date: January 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $12.2B Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 2.44% Avg Daily Range (30 D): $0.22 | 1.43% Avg Daily Range (90 D): $0.17 | 1.35% Institutional Daily Volume Avg Daily Volume: 2.86M Avg Daily Volume (30 D): 7.53M Avg Daily Volume (90 D): 5.9M Trade Size Avg Trade Size (Sh.): 150 Avg Trade Size (Sh.) (30 D): 167 Avg Trade Size (Sh.) (90 D): 165 Institutional Trades Total Inst.Trades: 3,018 Avg Inst. Trade: $3.51M Avg Inst. Trade (30 D): $4.23M Avg Inst. Trade (90 D): $4.1M Avg Inst. Trade Volume: .32M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $8.41M Avg Closing Trade (30 D): $14.72M Avg Closing Trade (90 D): $11.57M Avg Closing Volume: 766.27K     News Sep 17, 2025 @ 11:00 AM Roivant and Priovant Announce Positive Phase 3 VAL... Source: Roivant And Priovant Sep 16, 2025 @ 12:00 PM Imbria Pharmaceuticals Strengthens Leadership with... Source: Gina Mangiaracina Sep 4, 2025 @ 11:00 AM Pulmovant Receives Orphan Drug Designation in Japa... Source: Pulmovant Sep 3, 2025 @ 4:57 PM Immunovant Unveils Durability and Treatment-Free S... Source: Immunovant, Inc. Feb 20, 2025 @ 8:22 AM Will Moderna Stock Drop to $25? 1 Wall Street Anal... Source: Eric Volkman Financials   TTM Q1 2026 Q4 2025 Basic EPS $-.7 $-.33 $-.29 Diluted EPS $-.7 $-.33 $-.29 Revenue $ 23.23M $ 2.17M $ 7.57M Gross Profit $ $ $ Net Income / Loss $ -688.14M $ -273.91M $ -252.38M Operating Income / Loss $ -1185.98M $ -284.92M $ -284.97M Cost of Revenue $ $ $ Net Cash Flow $ -4448.99M $ -1477.87M $ 724.48M PE Ratio